Pinar Karaca Mandic
PhD 2004Economics, University of California at Berkeley
BA 1998Economics and Mathematics, High Honors, Swarthmore College
Pharmaceutical Use and Prescribing
Clinical Evidence Diffusion
Professor Pinar Karaca-Mandic teaches healthcare marketplace and medical technology evaluation. She is the C. Arthur Williams Jr. Professor in Healthcare Risk Management, and the Academic Director of the Medical Industry Leadership Institute (MILI) in the Department of Finance.
She is a Research Associate at the National Bureau of Economic Research (NBER), in Health Economics and Healthcare programs. She also serves as an Associate Editor of Forum for Health Economics and Policy, and an Editorial Board Member for the International Journal of Health Economics and Management.
Her research focuses on health insurance benefit design, healthcare regulations, insurance markets, pharmaceutical use, and medical technology diffusion. Dr. Karaca-Mandic’s research has been published in leading economics, medical and health policy journals including the Journal of Political Economy, Journal of Risk and Insurance, Journal of Health Economics, Journal of the American Medical Association (JAMA), British Medical Journal, Health Services Research and Health Affairs. Her research has been funded by the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality (AHRQ), The U.S. Department of Health and Human Services, Health Resources and Services Administration, and the Robert Wood Johnson Foundation. She was the recipient of a career grant from NIH through which she has been building a research agenda focused on understanding the mechanisms underlying the diffusion of new medical technologies. She is currently the Principal Investigator on an AHRQ funded project to study uptake of clinical evidence by providers focusing on de-adoption of treatments that are shown to be ineffective or harmful. She is also the Principal Investigator on a project funded by the American Cancer Society Funded to study uptake of biosimilar drugs in the U.S. markets.
Prior to joining the Carlson School faculty, Karaca-Mandic was Associate Professor of Health Policy and Management at the University of Minnesota’s School of Public Health.
She holds a Ph.D. in Economics from University of California at Berkeley, and BA in economics and mathematics, and a concentration in public policy from Swarthmore College.